INTERNATIONAL IMMUNOPHARMACOLOGY
·
2026
·
IF 4.7
Tianxiao Hu,Jiayu Qi,Yinuo Xu,Jia He,Qingying Tan,Jie Hao,Jing Wang,Jiewei Hong,Jianwei Wang,Lin Chen,Xiaobing Dou
This study aims to investigate the molecular mechanisms by which 4-hydroxynonenal (4-HNE) regulates hydrogen sulfide (H₂S)-producing enzymes, mediating the pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD) during pregnancy, thereby offering novel molecular targets for early diagnosis and intervention of related disorders. By establishing a MAFLD pregnant mouse model, we comprehensively examined the regulatory effects of 4-HNE on placental function and its interaction with the H₂S system. We found that MAFLD pregnant mice exhibited significant glucose metabolic disorders, hepatic steatosis, and placental damage. Mechanistically, 4-HNE disrupts H₂S biosynthesis, thereby impairing its inhibitory effect on the inflammasome pathway while simultaneously activating inflammatory cascades. This synergistic action exacerbates placental pathological damage, manifesting as abnormal vascular function and impaired materno-fetal exchange. Notably, exogenous H₂S intervention partially reversed 4-HNE-induced toxicity, suggesting the therapeutic potential of targeting this pathway. These findings demonstrate the pivotal role of the “4-HNE–H₂S–NLRP3” regulatory axis in MAFLD-associated placental injury, providing novel mechanistic insights and potential therapeutic targets for pregnancy complications.
✓ 已验证
DOI
PubMed
高影响因子
PHYTOMEDICINE
·
2026
·
IF 8.3
Xueling He,Chen Wang,Ruihao Zhang,Yuanyuan Wang,Ying Zhang,Tong Yang,Junzhe Zhang,Shuan Rao,Huan Tang,Xin Peng,Jigang Wang
Background Sepsis, a life-threatening condition, arises from an aberrant or uncontrolled immune response of the host to severe infection. Timely and precise control of this inflammatory response is of paramount importance in sepsis prevention and constitutes the core of sepsis prevention efforts. Parthenolide (PA), recognized as an NF-κB inhibitor, has previously demonstrated its capacity to mitigate the inflammatory response. This study aimed to investigate whether and how PA can inhibit inflammation, thereby alleviating sepsis, and to profile functional target proteins using chemoproteomics strategy. Methods The cecal ligation and puncture (CLP) procedure was performed to induce a mouse model of sepsis, and lipopolysaccharide (LPS) was employed to establish a model of cellular inflammation in mouse mononuclear macrophage cells (RAW264.7) in vitro . Enzyme-linked immunosorbent assay (ELISA) and hematoxylin and eosin (H&E) staining were utilized to evaluate the therapeutic effects of PA on septic mice. In the in vitro experiments, streamlined cysteine activity-based protein profiling (SLC-ABPP) and proteomics techniques were employed to identify potential protein targets and molecular pathways responsible for the anti-inflammatory properties of PA. Results We demonstrated that PA could enhance the survival rate, reduce inflammatory cytokines release, ameliorate histopathological changes, and balance macrophage polarization in a sepsis model. Similarly, PA could effectively alleviate the inflammatory response in LPS-stimulated RAW264.7 cells. Chemoproteomics profiling revealed that Trim33 protein was a potential covalent target of PA via cysteine engagement, and the expression changes of global proteins indicated by proteomics analysis suggested that PA mitigated inflammation by inhibiting the NF-κB pathway. Finally, through a series of molecular biology experiments, we confirmed that PA suppresses the NF-κB pathway by functionally binding to Trim33 and subsequently reducing the ubiquitin dependent degradation of Smad4, thereby exhibiting anti-inflammatory activity. Conclusion Our findings demonstrated that PA significantly mitigated inflammation in sepsis by targeting the Trim33 protein and consequently suppressing ubiquitination on Smad4 as well inhibiting the NF-κB pathway, thus providing new insights into the clinical use of PA in treatment of inflammation related diseases.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
BIOMATERIALS
·
2026
·
IF 12.9
Ning Cong,Lu Guo,Xiaoxuan Wang,Yading Zhao,Ting Zhao,Shuting Huang,Rui Liu,Song Ning,Xiaoying Zhou,Suyun Li,Yuye Fu,Jie Li
Cuproptosis is a novel form of cell death that relies on mitochondrial metabolism and has opened up new avenues for tumor therapy. However, resistance to cuproptosis in tumors can arise from several factors, such as their reliance on aerobic glycolysis, the high-glutathione (GSH) environment, and inefficient copper (Cu) delivery. In this study, we developed shell-core nanodroplets (NDs) approximately 280 nm in diameter, named Cu-EGCG-SHK-NDs. These NDs are composed of a liquid-gas phase-change perfluorohexane core and a carboxymethyl chitosan shell, loaded with the glycolytic inhibitor shikonin (SHK) and coated with Cu-complexed epigallocatechin gallate (Cu-EGCG), enabling targeted delivery through ultrasound (US)-targeted microbubble destruction (UTMD). The dual responsiveness of NDs to both US and pH enables precise drug release and efficient intracellular uptake. In addition, the US response enhances contrast-enhanced US imaging and triggers the generation of reactive oxygen species, subsequently depleting GSH. Both in vitr o and in vivo experiments confirm that Cu-EGCG-SHK-NDs possess excellent biocompatibility. Combined with UTMD, they can efficiently co-deliver Cu and SHK into tumour cells, inhibit glycolytic metabolism, and significantly reduce intracellular GSH levels. This synergistic mechanism enhances cuproptosis induction and achieves effective tumour growth inhibition.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
Cancer Nanotechnology
·
2026
·
IF 4.8
Chen Min,Wang Rui,Qiao Yang,Liu Menghui,Cheng Sheng,Dai Xingliang,Gao Peng,Zha Zhengjiang
Glioma remains one of the most aggressive brain tumors, necessitating innovative therapeutic strategies. Quercetin (Que), a natural polyphenolic flavonoid, has shown potential in cancer treatment. It can form iron-based nanodots (Que-Fe) that exhibit peroxidase (POD)-mimicking activity. This study aimed to synthesize and characterize Que-Fe nanodots, evaluate their photothermal conversion capabilities, and assess their anti-tumor efficacy both in vitro and in vivo. Que-Fe was synthesized through the coordination of Que with iron ions, yielding nanodots approximately 10 nm in diameter, confirmed by transmission electron microscopy and dynamic light scattering (DLS). The nanodots demonstrated significant POD-like activity in the presence of hydrogen peroxide. Photothermal experiments revealed that Que-Fe effectively converted near-infrared light into heat, achieving temperatures above 62 °C, indicating its potential as a photothermal agent. In vitro studies showed that Que-Fe exhibited concentration-dependent cytotoxicity against C6 glioma cells, with enhanced effects when combined with NIR irradiation. Transcriptomic analysis revealed that Que-Fe treatment upregulated genes associated with ferroptosis and oxidative stress, suggesting a multifaceted mechanism of action. In vivo experiments using a BALB/c nude mouse model demonstrated that Que-Fe, particularly in combination with NIR, significantly inhibited tumor growth and induced apoptosis without notable toxicity. Overall, these findings suggest that Que-Fe is a promising candidate for glioma therapy, leveraging its photothermal properties and inducing ferroptosis to enhance anti-tumor efficacy.
✓ 已验证
产品关联
DOI
高影响因子
Chinese Journal of Natural Medicines
·
2026
·Vol. 24
·期 1
·100-111
·
IF 4.9
Shanshan Li,Peiling Liu,Tiantian Zhang,Shujun Jiang,Faren Xie,Yanliang Zhang
Insects represent emerging sources of bioactive peptides and functional materials. Mantidis Oötheca (Sang-Piao-Xiao in Chinese, SPX) serves as an insect-derived medicine for treating kidney disease. This study demonstrated that supernatant (SPX) improved kidney function in adriamycin (ADR)-induced nephropathy mice model. Transcriptomic analysis revealed that SPX inhibited complement activation by targeting the MASP1-C3/C3a receptor (C3aR) pathway. Peptidomic analysis identified 304 peptides from SPX, with 49 peptides selected for evaluation using prediction tools and molecular docking with complement core protein C3. Three peptides (PMGFPFDR, FNDPK, AAQFFNR) exhibiting docking scores below −8.0 were synthesized to verify complement inhibition and anti-fibrotic activities. The synthetic peptide AAQFFNR demonstrated complement inhibitory activity, with an inhibitory complement hemolytic 50% (ICH 50 ) value of 24.54 μmol·L −1 , and exhibited superior protective effects in ADR-induced HK-2 cells. Surface plasmon resonance (SPR) assay revealed direct interaction between AAQFFNR and complement C3 with K d value of 16.8 μmol·L −1 . The reno-protective effect of AAQFFNR was subsequently verified in ADR-induced mice. This research provides initial evidence that complement C3-inhibiting peptides from insects demonstrate potential in preventing nephropathy through in silico and in vivo validation approaches.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
Chinese Journal of Natural Medicines
·
2026
·Vol. 24
·期 1
·89-99
·
IF 4.9
Wei Li,Guangming Li,Yi Wang,Yuxin Zhou
The activation of pancreatic stellate cells (PSCs) and the secretion of inflammatory factors play critical roles in the development of pancreatic fibrosis. While gambogic acid (GA), a flavonoid with anti-tumor properties, has been studied, its role in this process remains unclear. This study demonstrated that GA promoted YAP1 degradation and reduced its nuclear localization, thereby inhibiting PSC activation and the progression of pancreatic fibrosis. GA inhibited PSC proliferation, decreased α -smooth muscle actin ( α -SMA) expression, and reduced lipid droplets in LTC14 and primary mouse PSCs (mPSCs). Additionally, GA suppressed the expression of inflammatory factors [nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3), nuclear factor erythroid 2-related factor 2 (NRF2), interleukin-6 (IL-6), tumor necrosis factor α (TNF-α), and nuclear factor κ B (NF- κ B)] in PSCs and counteracted the transforming growth factor (TGF)-β-induced increase in these proteins. GA also reduced collagen Ι and tissue inhibitor of metalloproteinase-1 (TΙMP1) expression, thereby attenuating fibrosis. Mechanistically, GA decreased YAP1 expression and nuclear translocation and reversed TGF-β-induced YAP1 upregulation. YAP1 overexpression abrogated GA’s inhibitory effects on PSC activation and inflammation. Furthermore, GA activated the Hippo pathway, increased phosphorylated (p)-LATS1 and p-YAP levels, and promoted ubiquitin-mediated YAP1 degradation. In vivo studies confirmed that GA inhibited dibutyltin dichloride (DBTC)-induced pancreatic fibrosis via suppressing YAP1 and NF- κ B in BALB/c mice. In conclusion, GA activates the Hippo pathway and promotes YAP1 translocation to the cytoplasm, leading to its degradation and subsequent inhibition of PSC activation and fibrosis. These findings highlight the critical role of ubiquitin-mediated YAP1 degradation in regulating PSC activity and offer novel insights into the therapeutic potential of GA for treating pancreatic fibrosis.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
·
2026
·
IF 8.5
Chuyi Wang,Jingxin Chen,Nan Chen,Bingru Zhang,Wenyan Wu,Weiran Lin,Yuxin He,Jin Zhang,Yudong Lu,Zixing Yan
The half-life of the traditional Chinese medicine Anzhong Decoction (AZD) is relatively short. When administered orally, insufficient retention in the stomach and rapid clearance rates result in significantly reduced drug utilization efficiency. To address this limitation, we developed ternary composite sodium alginate/gelatin/guar gum hydrogel beads (SA/Gel/GG HBs) using ion-gelation technology. Research revealed that guar gum (GG) incorporation enhances hydrogen bonding and network heterogeneity, as confirmed by ATR-FTIR and rheological analysis. Specifically, the formulation containing 0.4% GG (SA/Gel/4GG) achieved an optimal balance of properties. It demonstrated an encapsulation efficiency of 76.09%, a loading capacity of 7.02% and a high-water retention of 85.24%. Crucially, SA/Gel/4GG sustained gastric flotation for over 6 h with a flotation rate exceeding 95.04%. This was attributed to its low-density closed-cell structure, featuring a density of 0.36 g/cm 3 and porosity of 17.10%. The optimized microsphere exhibited a first-order kinetic release mechanism with biphasic release characteristics. Within 6 h, 79.21% of AZD was released into gastric fluid, followed by sustained release in the intestine. The antioxidant activity of AZD against DPPH and ABTS was well preserved. This SA/Gel/GG system presents a promising gastric-floating oral delivery platform for traditional Chinese medicine compounds, effectively extending gastric retention and enabling controlled drug release.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
FOOD CHEMISTRY
·
2026
·
IF 9.8
Yujia Song,Li Tian,Ruidan Li,Yanjia Guo,Pengfei Han,Guangping Ma,Hanyue Jiang,Wenzhuo Wang,Tengying Ma
A highly sensitive molecular imprinting electrochemiluminescence (MIP-ECL) sensor was developed for Sudan III detection in food. The sensor utilized nitrogen-vacancy carbon nitride (CNNV) as an efficient ECL emitter in the S 2 O 8 2− system, with sea-urchin-like Pt Au nanoparticles (Pt Au NPs) and Ti 3 CN MXene serving as co-reaction accelerators and support material respectively to enhance signal intensity. Molecular imprinting was achieved using O -phenylenediamine (O-PD) as functional monomer, creating specific recognition sites for Sudan III. The detection mechanism was based on target-induced ECL quenching through electron transfer inhibition. The sensor showed excellent analytical performance with a wide linear range from 1 × 10 −12 to 1 × 10 −6 mol L −1 and an ultralow detection limit of 3.3 × 10 −13 mol L −1 (S/N = 3). Real sample analysis demonstrated good accuracy and precision. The sensor maintained 87.5% of initial response after 20-day storage, indicating good stability. This method provides a reliable approach for monitoring Sudan III in food.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
LIFE SCIENCES
·
2026
·
IF 5.1
Zhongquan Song,Yanmei Zhu,Surong Fang,Shuhua Han
Aims The EGFR-C797S mutation is the main cause of Osimertinib resistance. No effective treatment regimen is currently available for patients harboring EGFR-activation mutation/T790M/cis-C797S triple mutations. Materials and methods Nine patients with advanced non-small cell lung cancer (NSCLC) harboring EGFR-activation mutation/T790M/cis-C797S mutation were investigated. After Osimertinib resistance, these patients were treated with Endostar combination with Osimertinib. Network pharmacology and molecular dynamics simulations were used to clarify active sites of Endostar and the effect on protein conformation. In vivo and in vitro , EGFR L858R-T790M-C797S/H1975 cells were used to investigate the efficacy of co-treatment. Key findings Two patients achieved partial response (PR), six achieved stable disease (SD) and one had progressive disease (PD) at the 6-month efficacy assessment of co-treatment, resulting in an objective response rate (ORR) of 66.7% and a disease control rate (DCR) of 88.9%. These patients achieved a median progression-free survival (PFS) of 8.9 months and a median overall survival (OS) of 18.5 months, and no patients experienced grade III or IV adverse events. Endostatin, the active ingredient of Endostar, bound EGFR to “pseudo” mediate EGFR signaling pathway, and the introduction of Endostar enhanced the binding of Osimertinib to EGFR L858R/T790M/C797S protein. In vitro and in vivo experiments have found the co-treatment restored sensitivity to Osimertinib. Moreover, the combination therapy significantly inhibited the activation of the EGFR signaling pathway and tumor neovascularization. Significance This work demonstrated for the first time that Endostar enhanced the antitumor efficacy of Osimertinib, offering a potential therapeutic approach for patients harboring triple mutations.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
AQUACULTURE
·
2026
·
IF 3.9
Yi-Ran Zhao,Tong-Hao Wang,Ze-Xin Zhao,Xiao-Tian Niu,Hong-Ming Lv,Yan-Bing Li,Yang Cao,Mu-Yang Li
In the present study, we evaluated the effects of deoxynivalenol (DON) on intestinal oxidative stress, immunity, ferroptosis, and endoplasmic reticulum stress in Channa argus . Furthermore, we investigated the mechanism underlying DON-induced cytotoxicity by inhibiting ACSL4 in macrophages. In vivo analysis demonstrated DON inhibits growth and even leading to increased mortality. DON induces intestinal ROS and iron ion accumulation, thereby causing endoplasmic reticulum dysfunction and triggering oxidative stress and ferroptosis. This process is accompanied by decreased levels of ferroptosis-inhibiting proteins (GPX4, FPN1, and FSP1), along with increased ACSL4 and ROS levels. Furthermore, DON-induced ROS accumulation elicits endoplasmic reticulum dysfunction and drives the progression of immunosuppression and inflammation. In vitro analysis demonstrated that inhibition of ACSL4 affects macrophage activity as well as ROS and ATP levels, representing a potential intervention strategy to restore immune cell function. This study demonstrates that targeting ACSL4 may serve as a potential strategy for alleviating DON-mediated intestinal injury in C. argus .
✓ 已验证
产品关联
DOI
高影响因子
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
·
2026
·
IF 4.9
Jing Zhang,Jing Wen,Tie Li,Junshuang Xu,jinbiao Ma,Min Hong,Wei Li
Hyperuricemia (HU), a common metabolic disorder, is characterized by elevated serum uric acid (sUA) levels. Uricase, an enzyme that degrades uric acid(UA) into allantoin, is absent in humans due to a nonsense mutation. Messenger RNA (mRNA)-based protein replacement therapy, known for its efficiency and transient expression, has garnered significant research attention. This study focuses on developing a mRNA therapy for HU using human ancestral uricase ANC19, delivered via lipid nanoparticles (LNPs). We prepared ANC19-LNPs, characterized their physicochemical properties, and evaluated their expression and function in Huh7 cells. Results indicate successful preparation and characterization of ANC19-mRNA, which localizes to peroxisomes and demonstrates UA degradation capability in vitro. Biodistribution was validated in Balb/c mice. Concurrently, a HU mouse model was successfully established using siRNA-mediated knockdown of Uricase-mRNA. In HU mouse models, ANC19-LNPs achieved a 75.63% UA degradation rate. To validate these promising findings in a more clinically relevant species, the therapy was evaluated in cynomolgus monkeys, where it also showed a therapeutic effect, the area under the curve (AUC) of the concentration-time curve for ANC19-LNPs was 32.647 h*μg/mL compared to 67.074 h*μg/mL for the negative control. Biochemical blood tests in cynomolgus monkeys confirmed the safety of ANC19-LNPs. In conclusion, we have successfully developed an effective mRNA-based protein replacement therapy for UA degradation, showing promising efficacy and safety in both in vitro and in vivo studies.
✓ 已验证
产品关联
DOI
高影响因子
SEPARATION AND PURIFICATION TECHNOLOGY
·
2026
·
IF 9
Ruifang Qi,Yue Zhao,Jinming Lei,Huixian Jia,Chenghong Feng
Metal-free covalent organic frameworks (COFs) often face a critical trade-off wherein high photocatalytic activity relies on complex, expensive designs while cost-effective alternatives lack efficiency and stability. To address these issues, a nitro-functionalized COF (COF-NO₂) was developed via a one-step condensation method for bisphenol A (BPA) degradation. The –NO₂ groups act as intramolecular electron traps, narrowing the bandgap and boosting charge separation. COF-NO₂ achieved 97.3% BPA degradation within 120 min ( k = 0.031 min −1 ) with over 85% efficiency across five consecutive cycles. Moreover, it exhibited high efficiency across a broad pH range (3−11) and showed broad-spectrum activity toward various bisphenols, including bisphenol S, bisphenol F, bisphenol C, and 4-chlorophenol. Quantitative structure–activity relationship analysis identified HOMO energy as the key descriptor governing degradation kinetics for bisphenols. In pretreated petrochemical wastewater, COF-NO₂ also attained over 75% BPA removal, demonstrating practical potential. This molecular design promoted ·O₂ − generation and selective bond cleavage in BPA, thereby enabling efficient mineralization and a 44% reduction in toxicity. A continuous-flow fluidized bed reactor was designed and achieved 97.4% BPA removal in 180 min through optimized light-flow coupling. Furthermore, low-cost g-C₃N 4 was introduced to integrate with highly active COF-NO₂, forming a composite that reduced material costs by 20% while maintaining over 80% degradation efficiency. This work presents a synergistic strategy combining molecular orbital engineering with heterojunction design, offering a feasible route to cost-effective and scalable metal-free COFs.
✓ 已验证
产品关联
DOI
高影响因子